Drugs / Tetanus Diphtheria Vaccine
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05096481 Background | Jul 2024 → Jun 2028 expected | diffuse intrinsic pontine glioma, high grade astrocytic tumor, medulloblastoma | Nationwide Children's Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tetanus Diphtheria Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05096481 ↗ |
| Modality | Vaccine | “Immunotherapy begins with a Td pre-conditioning vaccine” NCT05096481 ↗ |
| Route | Other | “delivered i.d. at the RIGHT groin site of the vaccine injection” NCT05096481 ↗ |